Traditional Chinese medicine composition for treating chronic and acute liver failure enterogenic endotoxemia and enema

A technology for endotoxemia and liver failure intestine, which is applied in the directions of drug combination, drug delivery, pharmaceutical formulation, etc., and can solve the problem that polymyxin b hinges need further verification, need further observation and evaluation, and cannot be effectively cleared. Endotoxin and other problems, to achieve the effect of enriching the capillary network, improving local microcirculation, and convenient and easy treatment

Inactive Publication Date: 2016-04-06
THE FIRST AFFILIATED HOSPITAL OF HENAN UNIV OF TCM
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] 1. Polymyxin b is considered to be the only antibiotic with anti-endotoxin effect, but it is limited to severe adverse reactions that damage the kidney and cannot be directly applied to anti-endotoxin treatment in vivo; in recent years, the hinges produced by drug hinge technology are mostly The effectiveness of the myxomycin b complex and the stability of the polymyxin b hinge need to be further verified, and this new technology for applying polymyxin b is still in the stage of experimental exploration;
[0006] 2. Blood purification technology: It is a pioneering work to apply blood purification technology to the treatment of endotoxemia. However, because endotoxin is a high-molecular substance, hemodialysis alone cannot effectively remove endotoxin. Plasma proteins, especially albumin, have a high affinity with lipopolysaccharide, which can partially remove the free endotoxin in the patient's plasma. However, this technology consumes a lot of materials, is expensive, and the curative effect is not ideal. The ratio of effect to cost is very low. Low, difficult to promote;
[0007] 3. Anti-lipopolysaccharide and anti-inflammatory mediators: monoclonal antibody preparations including E5 and HA-1A are considered to bring new hope to the treatment of endotoxemia, and the short-term efficacy of clinical trial treatment has achieved initial results. It is considered to be the most promising treatment method, but more and more clinical trials report that the long-term efficacy and safety of anti-lipopolysaccharide antibodies need further observation and evaluation
[0013] The above-mentioned technical scheme is a beneficial attempt to treat endotoxemia with traditional Chinese medicine, but there are also flaws. Only using the active ingredients of traditional Chinese medicine to treat endotoxemia is contrary to the compatibility principle of traditional Chinese medicine. Each Chinese medicine contains a variety of For chemical components, it is biased to extract the main components alone to treat diseases, which can not only cause a waste of traditional Chinese medicine resources, but also lose active ingredients, because the combination of traditional Chinese medicines requires complex chemical reactions to improve the curative effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine composition for treating chronic and acute liver failure enterogenic endotoxemia and enema
  • Traditional Chinese medicine composition for treating chronic and acute liver failure enterogenic endotoxemia and enema
  • Traditional Chinese medicine composition for treating chronic and acute liver failure enterogenic endotoxemia and enema

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] A traditional Chinese medicine composition for treating enterogenous endotoxemia in acute-on-chronic liver failure, consisting of the following raw materials:

[0029] Rhubarb 25g, Magnolia officinalis 15g, Citrus aurantium 16g, Chishao 30g, Ume 14g, Gongying 30g, Coptis 13g.

[0030] The Chinese medicine composition is prepared into an enema, and the following steps are carried out:

[0031] Mix the above-mentioned raw materials evenly, add 200ml of water to cover the medicinal surface, soak for 30 minutes, decoct the medicine for the first decoction to 100ml, add 200ml of water for the second decoction, and decoct to 100ml, combine the decoction each time to get .

Embodiment 2

[0033] A traditional Chinese medicine composition for treating enterogenous endotoxemia in acute-on-chronic liver failure, consisting of the following raw materials:

[0034] Rhubarb 20g, Magnolia officinalis 20g, Citrus aurantium 10g, Radix Paeoniae Rubra 40g, Ume 10g, Gongying 40g, Coptis 10g.

[0035] The method for preparing the Chinese medicine composition into an enema is the same as in Example 1.

Embodiment 3

[0037] A traditional Chinese medicine composition for treating enterogenous endotoxemia in acute-on-chronic liver failure, consisting of the following raw materials:

[0038] Rhubarb 30g, Magnolia officinalis 10g, Citrus aurantium 20g, Radix Paeoniae Rubra 20g, Ume 20g, Gongying 20g, Coptis 15g.

[0039] The method for preparing the Chinese medicine composition into an enema is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a traditional Chinese medicine composition for treating chronic and acute liver failure enterogenic endotoxemia. The composition is prepared from, by weight, 20-23 parts of rhubarb, 10-20 parts of cortex magnoliae officinalis, 10-20 parts of fructus aurantii immaturus, 20-40 parts of red peony roots, 10-20 parts of fructus mume, 20-40 parts of dandelions and 10-15 parts of coptidis rhizomes. The traditional Chinese medicine composition can be prepared into an enema through the method including the steps that all the raw materials are evenly mixed, water is added and gets over the medicine surface, the materials are soaked for 20-40 min and decocted for two to five times, decoction solutions obtained each time are combined, and the enema is obtained. The traditional Chinese medicine enema can be used for treating enterogenic endotoxemia, protecting intestinal mucosa, improving intestinal flora and facilitating disease recovery, the length of stay can be shortened, and medical cost is reduced.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine composition and an enema for treating acute-on-chronic liver failure enterogenous endotoxemia. Background technique [0002] Acute-on-chronic liver failure is a short-term clinical syndrome of acute or subacute liver function decompensation on the basis of chronic liver disease, manifested as extreme fatigue, obvious gastrointestinal symptoms, rapidly deepening jaundice, obvious bleeding tendency, ascites, etc. Its condition is critical and the mortality rate is high. Regarding the pathogenesis of liver failure, some scholars have put forward the triple-hit hypothesis in recent years, that is, liver failure caused by HBV undergoes a triple fatal blow of immune injury, ischemia-hypoxic injury, and endotoxemia in sequence. Intestinal endotoxemia and liver damage are mutually causal, and play a key role in the occurrence and de...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/752A61P1/16A61P1/00A61P31/04
CPCA61K9/0031A61K9/10A61K36/288A61K36/575A61K36/65A61K36/708A61K36/71A61K36/718A61K36/736A61K36/752A61K2236/331A61K2236/39A61K2300/00
Inventor 张照兰马素平王晓王伟吕莹刘杨春
Owner THE FIRST AFFILIATED HOSPITAL OF HENAN UNIV OF TCM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products